Pulmonary drug delivery (AlphazerTM) > Target markets

In the pulmonary drug delivery market, Omega Life Science addresses the following sub-categories:

• Drugs that are currently administered by injection

• Oral drugs with liver-toxicity or gastrointestinal uptake issues

• Drugs administered in large doses that currently require long nebulizing time

• Low solubility drugs

• Biologics and other sensitive APIs.

• Delivery of small molecules as well as large proteins.

• Drugs requiring fast uptake and improved biological response.